首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1269705

2022-2029年全球腎臟生物標記市場規模研究與預測，按生物標記類型、診斷技術（終端用戶和區域分析）分類

Global Renal Biomarkers Market Size study & Forecast, by Biomarker type by Diagnostic Technique (, by End User and Regional Analysis, 2022-2029

出版日期: 2023年05月05日 | 出版商:

Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

生物標記是生物體的一種生物特徵，評估為典型生物功能的標誌。腎臟生物標記是識別急性和慢性腎臟損傷以及其他一些腎臟疾病的重要診斷工具。腎臟疾病的治療主要是利用腎臟生物標記。這些生物標記在研究和臨床方面都有幫助，用於分析腎臟系統的功能。腎臟生物標記市場擴大，因為各種腎臟相關疾病的發病率不斷增加，以及慢性腎臟疾病的進展速度不斷提高等因素。

2022年4月的一篇腎臟國際補充劑文章指出，全世界每年有數百萬人死於慢性腎臟疾病，這影響到世界人口的10%左右。慢性腎髒病人正變得越來越普遍。另外，與西方國家相比，亞洲國家與糖尿病相關的慢性腎臟疾病的發病率明顯更高。例如，根據國際糖尿病聯合會2021年的一份報告，印度在2021年估計有74,194.7萬例糖尿病，到2030年，這一數位預計將上升到92,973.7萬例。因此，預計在預測期內，由於腎臟疾病及其相關原因的發病率上升，對腎臟疾病診斷的需求將上升。這將推動生物標記的發展。此外，市場參與者在遺傳技術領域的進步和產品開發的戰略活動正在創造有利的市場成長。然而，腎臟生物標記的高成本可能會阻止市場成長。

全球腎臟生物標記市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌產品的主導地位和該地區日益成長的疾病流行率，北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年成長率成長，原因是老年病和目標人群的增加，產品開發合作的數量增加，主要參與者的地理擴張，以及政府和非營利組織對市場空間的積極參與等因素。

該研究的目的是確定近年來不同領域和國家的市場規模，並對未來幾年的價值進行預測。本報告旨在將研究涉及的國家內的產業的品質和數量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，它還包括微觀市場的潛在機會，供利益相關者投資，以及對競爭格局和主要參與者的生物標記類型的詳細分析。

市場簡介
2019-2029年全球和細分市場的估計和預測
- 2019-2029年腎臟生物標記市場，按地區分類
- 2019-2029年腎臟生物標記市場，按生物標記類型
- 2019-2029年腎臟生物標記市場，按診斷技術分類
- 2019-2029年腎臟生物標記市場，按終端用戶分類
主要趨勢
估算方法
研究假設

第二章：全球腎臟生物標記市場的定義和範圍

本研究的目的
市場定義和範圍
- 研究的範圍
- 產業演變
研究考慮的年份
貨幣兌換率

第三章：全球腎臟生物標記市場動態

腎臟生物標記市場影響分析（2019-2029年）
- 市場驅動力
  - 各種腎臟相關疾病的發病率不斷增加、
  - 慢性腎臟疾病的進展率不斷上升
- 市場挑戰
  - 腎臟生物標記的高成本
- 市場機會
  - 遺傳技術領域的進步
  - 市場參與者開發產品的戰略活動

第四章：全球腎臟生物標記市場產業分析

波特的五力模型
- 供應商的議價能力
- 買方的議價能力
- 新進入者的威脅
- 替代品的威脅
- 競爭性的競爭
波特五力模型的未來方法（2019-2029年）
PEST分析
- 政治因素
- 經濟
- 社會
- 技術
最佳投資機會
最佳策略
產業專家展望
分析師建議和結論

第五章：風險評估：COVID-19的影響

評估COVID-19對產業的整體影響
COVID-19前和COVID-19後的市場情況

第六章：全球腎臟生物標記市場，按生物標記類型分類

市場簡介
全球腎臟生物標記市場，按生物標記類型，性能-潛力分析
2019-2029年全球腎臟生物標記市場按生物標記類型估計和預測的情況
腎臟生物標記市場，細項分析
- 功能性生物標記
- 上調的蛋白質
- 其他生物標記類型

第7章：全球腎臟生物標記市場，按診斷技術分類

市場簡介
按診斷技術分類的全球腎臟生物標記市場，表現- 潛力分析
2019-2029年全球腎臟生物標記市場按診斷技術的估計和預測
腎臟生物標記市場，細項分析
- 酶聯免疫吸附分析法
- 顆粒增強濁度免疫分析法（PETIA)
- 比色法
- 化學發光酶聯免疫分析法（CLIA）
- 液相色譜-質譜法（LS-MS）。

第八章：全球腎臟生物標記市場，按終端用戶分類

市場簡介
按終端用戶分類的全球腎臟生物標記市場，性能-潛力分析
2019-2029年全球腎臟生物標記市場按終端用戶估計和預測的情況
腎臟生物標記市場，細項分析
- 醫院
- 診斷實驗室
- 其他終端用戶

第九章：全球腎臟生物標記市場，區域分析

腎臟生物標記市場，區域市場簡介
北美洲
- 美國
  - 2019-2029年，生物標記類型的細分估計和預測
  - 診斷技術分類估計和預測，2019-2029年
  - 2019-2029年終端用戶分類估計和預測
- 加拿大
歐洲腎臟生物標記市場簡介
- 英國
- 德國
- 法國
- 西班牙
- 意大利
- 歐洲其他地區
亞太地區腎臟生物標記市場簡況
- 中國
- 印度
- 日本
- 澳大利亞
- 韓國
- 亞太其他地區
拉美腎臟生物標記市場簡介
- 巴西
- 墨西哥
- 拉美其他地區
世界其他地區

第十章：競爭情報

頂級市場戰略
公司簡介
- Abbott Laboratories
  - 關鍵資訊
  - 概況
  - 財務（取決於數據的可用性）
  - 產品摘要
  - 近期發展情況
- BioPorto Diagnostics AS
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Nexelis (Pacific Biomarkers)
- BioMerieux
- Sphingotec GmbH
- Randox Laboratories Ltd
- Siemens Healthineers AG
- Enzo Life Sciences, Inc.

第十一章：研究過程

研究過程
- 資料探勘
- 數據分析
- 市場評估
- 驗證
- 出版
研究屬性
研究假設

簡介目錄圖表

Global Renal Biomarkers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A biomarker is a biological characteristic of an organism that is assessed as a sign of typical biological function. Renal biomarkers are a crucial diagnostic tool for identifying both acute and chronic kidney injury as well as several other kidney disorders. Renal disorders are primarily treated using renal biomarkers. These biomarkers are helpful in both research and clinical contexts and are used to analyze the renal system's functionality. The Renal Biomarkers Market is expanding because of factors such as the increasing incidence of various kidney-related diseases, and the increasing rate of progression of chronic kidney disease.

A Kidney International Supplements article from April 2022 claims that millions of people worldwide pass away each year from chronic kidney disease, which affects about 10% of the world's population. Chronic renal disease individuals are becoming more prevalent. Also, compared to Western nations, Asian nations had a significantly higher incidence of diabetes-related chronic renal illnesses. For instance, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Thus, it is anticipated that over the projection period, demand for renal disease diagnosis would rise in response to the rising prevalence of kidney illnesses and their associated causes. This will fuel the development of biomarkers. Furthermore, advancements in the field of genetic technology strategic activities by market players for product development are creating lucrative growth in the market. However, the high cost of renal biomarkers may halt market growth.

The key regions considered for the Global Renal Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

Abbott Laboratories
BioPorto Diagnostics AS
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Nexelis (Pacific Biomarkers)
BioMerieux
Sphingotec GmbH
Randox Laboratories Ltd
Siemens Healthineers AG
Enzo Life Sciences, Inc.

Recent Developments in the Market:

In December 2022, the company Journey Biosciences, Inc. has announced the release of NaviDKD, its flagship product, a blood test based on biomarkers that forecast long-term kidney issues in diabetics. The only screening method that gives diabetics a head starts on the risk of developing kidney disease.
In March 2022, Renalytix plc has announced the launch of myIntelX, a new provider access portal that will enable doctors to order KidneyIntelX prognostic (blood-based biomarker) testing online for more accurate identification of patients at the highest risk of rapid progression of kidney disease in type 2 diabetes.

Global Renal Biomarkers Market Report Scope:

Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Biomarker type, Diagnostic Technique, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Biomarker typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Biomarker Type:

Functional Biomarker
Up-regulated Protein
Other Biomarker Types

By Diagnostic Technique:

Enzyme-linked Immunosorbent Assay
Particle-enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography-mass Spectrometry (LS-MS)

By End User:

Hospitals
Diagnostic Laboratories
Other End Users

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Renal Biomarkers Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Renal Biomarkers Market, by Biomarker Type, 2019-2029 (USD Billion)
- 1.2.3. Renal Biomarkers Market, by Diagnostic Technique, 2019-2029 (USD Billion)
- 1.2.4. Renal Biomarkers Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Renal Biomarkers Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Renal Biomarkers Market Dynamics

3.1. Renal Biomarkers Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of various kidney-related diseases,
  - 3.1.1.2. increasing rate of progression of chronic kidney disease
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Renal Biomarkers
- 3.1.3. Market Opportunities
  - 3.1.3.1. Advancements in the field of genetic technology
  - 3.1.3.2. Strategic activities by market players for product development

Chapter 4. Global Renal Biomarkers Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Renal Biomarkers Market, by Biomarker Type

6.1. Market Snapshot
6.2. Global Renal Biomarkers Market by Biomarker Type, Performance - Potential Analysis
6.3. Global Renal Biomarkers Market Estimates & Forecasts by Biomarker Type 2019-2029 (USD Billion)
6.4. Renal Biomarkers Market, Sub Segment Analysis
- 6.4.1. Functional Biomarker
- 6.4.2. Up-regulated Protein
- 6.4.3. Other Biomarker Types

Chapter 7. Global Renal Biomarkers Market, by Diagnostic Technique

7.1. Market Snapshot
7.2. Global Renal Biomarkers Market by Diagnostic Technique, Performance - Potential Analysis
7.3. Global Renal Biomarkers Market Estimates & Forecasts by Diagnostic Technique 2019-2029 (USD Billion)
7.4. Renal Biomarkers Market, Sub Segment Analysis
- 7.4.1. Enzyme-linked Immunosorbent Assay
- 7.4.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)
- 7.4.3. Colorimetric Assay
- 7.4.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 7.4.5. Liquid Chromatography-mass Spectrometry (LS-MS)

Chapter 8. Global Renal Biomarkers Market, by End User

8.1. Market Snapshot
8.2. Global Renal Biomarkers Market by End User, Performance - Potential Analysis
8.3. Global Renal Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Renal Biomarkers Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Diagnostic Laboratories
- 8.4.3. Other End Users

Chapter 9. Global Renal Biomarkers Market, Regional Analysis

9.1. Renal Biomarkers Market, Regional Market Snapshot
9.2. North America Renal Biomarkers Market
- 9.2.1. U.S. Renal Biomarkers Market
  - 9.2.1.1. Biomarker Type breakdown estimates & forecasts, 2019-2029
  - 9.2.1.2. Diagnostic Technique breakdown estimates & forecasts, 2019-2029
  - 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Renal Biomarkers Market
9.3. Europe Renal Biomarkers Market Snapshot
- 9.3.1. U.K. Renal Biomarkers Market
- 9.3.2. Germany Renal Biomarkers Market
- 9.3.3. France Renal Biomarkers Market
- 9.3.4. Spain Renal Biomarkers Market
- 9.3.5. Italy Renal Biomarkers Market
- 9.3.6. Rest of Europe Renal Biomarkers Market
9.4. Asia-Pacific Renal Biomarkers Market Snapshot
- 9.4.1. China Renal Biomarkers Market
- 9.4.2. India Renal Biomarkers Market
- 9.4.3. Japan Renal Biomarkers Market
- 9.4.4. Australia Renal Biomarkers Market
- 9.4.5. South Korea Renal Biomarkers Market
- 9.4.6. Rest of Asia Pacific Renal Biomarkers Market
9.5. Latin America Renal Biomarkers Market Snapshot
- 9.5.1. Brazil Renal Biomarkers Market
- 9.5.2. Mexico Renal Biomarkers Market
- 9.5.3. Rest of Latin America Renal Biomarkers Market
9.6. Rest of The World Renal Biomarkers Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. Abbott Laboratories
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. BioPorto Diagnostics AS
- 10.2.3. F. Hoffmann-La Roche AG
- 10.2.4. Thermo Fisher Scientific Inc.
- 10.2.5. Nexelis (Pacific Biomarkers)
- 10.2.6. BioMerieux
- 10.2.7. Sphingotec GmbH
- 10.2.8. Randox Laboratories Ltd
- 10.2.9. Siemens Healthineers AG
- 10.2.10. Enzo Life Sciences, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

簡介目錄圖表

LIST OF TABLES

TABLE 1. Global Renal Biomarkers Market, report scope
TABLE 2. Global Renal Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Renal Biomarkers Market estimates & forecasts by Biomarker Type 2019-2029 (USD Billion)
TABLE 4. Global Renal Biomarkers Market estimates & forecasts by Diagnostic Technique 2019-2029 (USD Billion)
TABLE 5. Global Renal Biomarkers Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Renal Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Renal Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Renal Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Renal Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Renal Biomarkers Market
TABLE 71. List of primary sources, used in the study of global Renal Biomarkers Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered